Ledger.Open graph →
SEC Form D · filed July 8, 2014

Beta Cat Pharmaceuticals, Inc

Offering
$500K
Sold
$500K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Alain C. Cappeluti · Gaithersburg, MDExecSunil C. Sharma · Gaithersburg, MDExec · DirectorJonathan P. Northrup · Gaithersburg, MDExec · DirectorKenneth C. Carter · Gaithersburg, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗